Surveillance decision

Surveillance decision

We will not update the guideline on bladder cancer: diagnosis and management.

Reasons for the decision

The majority of evidence was found to be consistent with the current guideline recommendations. Improvements were seen in the area of robotic cystectomy for some patient outcomes, however as the guideline does not currently state which method of radical cystectomy should be used, there is unlikely to be an impact at this time. New evidence was found for urinary biomarkers but was found to support the current recommendations in this area.

For further details and a summary of all evidence identified in surveillance, see appendix A.


This page was last updated: 05 April 2019